Hims & Hers Health Announced on Wednesday that it took over the laboratory test facility in New Jersey based in New Jersey.
The deal enables the Telemealth company to be able to offer its users blood streets and more comprehensive pretreatment tests.
“Access to richer data enables us to deepen the findings that providers can use on our platform to guide your clinical decisions for each individual patient,” said Dr. Patrick Carroll, Chief Medical Officer from Hims & Hers.
“Laboratory tests at home are another exciting step to improve personal, comprehensive nursing customers in this country,” added Carroll.
HIMS did not disclose the conditions of the deal, but said it financed it through bar at hand. The company announced CNBC that the pricing for the new test options would issue if the offer will be made available to customers next year.
The acquisition by HIMS & HISS offers a competition for blood corporation services such as Labcorp and Quest Diagnostics.
The startup extends its services by less than a year after offering weight loss medication with weight loss of GLP-1. When HIMS & HER throws itself as a cheaper alternative to established companies, it has recently been aimed at a Super Bowl display on the pharmaceutical industry and said that the industry was “for profits, not for patients”.
“The health care that customers expect today and earn today is the care of which with treatments that have been specially developed for them,” said Dr. Carroll.
While the company of the company was Volatil, Wall Street bought this year: the shares rose by 141% in 2025.
The new acquisition will add test functions for LDL cholesterol, lipoprotein (a), cholesterol and apolipoprotein, according to the company. The company's ability to offer access and treatments over a number of diseases will also expand, including low testosterone and pre-menopausal and menopause support.
The Tasso+ device is a blood lance that collects entire liquid blood samples. Several standard collection pipes are compatible. Tasso+ is the FDA -Class II Lancet 510 (K) -Cleared. “
With kind permission: Tasso Inc.
HIMS users receive a blood lance with Home Diagnostic Testing Company Tasso. The lancet is a disposable device that collects entire liquid blood samples and is deleted by the FDA for the use of Premarket.
Users attach the device to your upper arm and press a button that triggers the lancet to sting the skin and draw a small amount of blood collected in a microtube.
Providers on the platform use the information that was collected as part of a treatment plan for patients.
HIMS & HERS said that data from the blood test will use patient identities-to accelerate the development of AI-driven health care.
Comments are closed.